Supplementary materials.docx (234.73 kB)
Download file

Supplementary materials: Cost-effectiveness of brentuximab vedotin for the treatment of cutaneous T-cell lymphoma.docx

Download (234.73 kB)
posted on 2021-12-09, 09:19 authored by Tanja Podkonjak, Holly Cranmer, Julia Scarisbrick, Grant McCarthy, Cameron Lilley, Lung-I Cheng

Table A1. Clinical Inputs.

Table A2. Cost Inputs.

Table A3: Resource utilization.

Table A4. Utility inputs.

Figure A1. Probabilistic sensitivity analysis scatterplot.


Funded by Takeda Pharmaceuticals International Co.